Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Nightstar Therapeutics Plc ADR (NITE)

$25.41 0.00 (0.00%)

6:14 EDT NITE Stock Quote Delayed 15 Minutes

Volume:

Previous Close -

Market Cap 734.35M

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 25.41 - 25.41

52-Week Range 9.59 - 27.50

Dividend & Yield N/A (N/A)

NITE Stock Predictions, Articles, and Nightstar Therapeutics Plc ADR News

From InvestorPlace
From the Web

NITE, BIIB: Nightstar Therapeutics Stock Soars on Biogen Buy

By William White, InvestorPlace Writer Mar 4, 2019

Nightstar Therapeutics stock was soaring on Monday following news that Biogen (BIIB) is acquiring the company for $877 million.

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

7 Lucrative Biotech Stocks With Up to 300% Upside

By Harriet Lefton, Writer, TipRanks Sep 6, 2018

These seven biotech stocks all have support from Wall Street's top-performing analysts and have eye-watering upside potential ahead.

Play The Future of Gene Therapy With These 5 Biotech Stocks

By Aaron Levitt, InvestorPlace Contributor Aug 27, 2018

What's the next big thing in biotech? The answer is gene therapy and these five biotech stocks are leading the way.

Biogen Leads List of Drugmakers Left to Make a Needed M&A Splash

From Bloomberg Jun 25, 2019

Biotechnology investors who have popped corks to celebrate the wave of deals in the first half of 2019 can set their sights on the remainder of companies that have stayed passive to start the year.

Gene-Therapy Firm UniQure Explores Options Including Sale

From Bloomberg Jun 16, 2019

UniQure NV is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy, people with knowledge of the matter said.

Biogen completes Nightstar buy

From Seeking Alpha Jun 7, 2019

Biogen (NASDAQ:BIIB) has completed its acquisition of Nightstar Therapeutics (NASDAQ:NITE) for ~$800M.As a result of the acquisition, Biogen now has added two mid- to late-stage clinical assets, as we

Biogen acquires Nightstar for $800M

From Seeking Alpha Jun 7, 2019

Biogen (NASDAQ:BIIB) has completed its acquisition of Nightstar Therapeutics (NASDAQ:NITE) for ~$800M.As a result of the acquisition, Biogen now has added two mid- to late-stage clinical assets, as we

Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout

From Investor's Business Daily May 17, 2019

Dow Jones component Johnson & Johnson could buy out biotech stock MeiraGTx for its efforts in gene therapy, an analyst suggested Friday.

Celgene Stock Breaks Out As Bristol Grabs Key Merger Endorsement

From Investor's Business Daily Mar 29, 2019

Celgene stock broke out Friday after two proxy advisory firms voted in favor of Bristol-Myers Squibb's looming Celgene acquisition.

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!